Why are sulfamethoxazole and trimethoprim selectively toxic to bacteria rather than human cells?
Choose an answer, then check it.
Clinical Pharmacology · Antibacterial Medications
Folate Antagonists
On this page 6 sections
In 30 seconds
Folate antagonists — sulfamethoxazole and trimethoprim, almost always paired as one combination drug — starve bacteria of folate they must build themselves, while human cells simply absorb folate from food and are spared. Each drug alone only slows bacterial growth, but blocking two steps of the same pathway together kills the organism outright, a classic example of synergy. The combination treats infections from routine urinary tract infections to Pneumocystis pneumonia in immunocompromised patients, and it carries a distinctive, sometimes serious side-effect profile.
The college version
The Folate Pathway and Selective Toxicity
Folate (vitamin B9) is essential for synthesizing the building blocks of DNA and RNA. Bacteria cannot import folate from their environment the way human cells absorb it from the diet; they must construct it de novo from simpler precursors, including para-aminobenzoic acid (PABA). This difference — obligate synthesis in bacteria versus dietary absorption in humans — is why these drugs act with a wide margin of safety against the host while devastating the pathogen, exploiting a pathway humans do not functionally possess.
Two Sequential Blocks, One Pathway
Sulfamethoxazole is a structural analogue of PABA. It competitively inhibits dihydropteroate synthase, the bacterial enzyme that combines PABA with a pteridine precursor to begin building folate. Trimethoprim acts one step downstream, inhibiting dihydrofolate reductase, which converts dihydrofolate into its active form, tetrahydrofolate — the cofactor bacteria need for nucleotide synthesis. Trimethoprim's target enzyme differs enough from the human version that it spares human dihydrofolate reductase at clinical doses.
Alone, each drug is merely bacteriostatic: it slows bacterial growth enough for the immune system to finish the job, but does not reliably kill outright. Combined, the two create a sequential, two-point blockade of one pathway. This dual hit is synergistic and bactericidal, which is why the agents are prescribed together rather than either alone.
Clinical Uses
Trimethoprim-sulfamethoxazole is a workhorse for uncomplicated urinary tract infections and a first-line option for community-acquired MRSA skin and soft tissue infections. It is central to treating and preventing Pneumocystis jirovecii pneumonia in patients with advanced HIV or other significant immunosuppression, and it is used for toxoplasmosis prophylaxis in similarly vulnerable populations. It also treats less familiar organisms including Nocardia and Stenotrophomonas maltophilia, both often resistant to more conventional antibiotics.
Adverse Effects
Hypersensitivity reactions, especially rash, are common, and at the severe end the sulfonamide component is associated with Stevens-Johnson syndrome and toxic epidermal necrolysis, involving widespread skin and mucosal breakdown. Trimethoprim resembles the potassium-sparing diuretic amiloride and produces a similar effect on the distal renal tubule, blunting potassium secretion and predisposing to hyperkalemia. It also inhibits tubular creatinine secretion, raising measured serum creatinine without reflecting any true decline in glomerular filtration. Because the combination interferes with folate metabolism, it can cause bone marrow suppression with megaloblastic changes, amplified in patients already folate-deficient. Sulfonamides are poorly soluble and can precipitate in urine, causing crystalluria, so adequate hydration is emphasized. Photosensitivity, hemolytic anemia in G6PD deficiency, and bilirubin displacement from albumin — raising kernicterus risk in neonates — round out the concerns, making the combination inadvisable near term and in young infants.
Interactions and Related Agents
Sulfonamides displace warfarin from protein binding and inhibit its metabolism, potentiating anticoagulation. The combination raises methotrexate toxicity by additively impairing folate metabolism, and compounds hyperkalemia from ACE inhibitors, angiotensin receptor blockers, and potassium-sparing diuretics. Sulfadiazine, another sulfonamide, pairs with pyrimethamine for toxoplasmosis and shares the class's hypersensitivity risks. Dapsone, related in structure and sharing the PABA-antagonist logic and G6PD hemolysis risk, treats leprosy and serves as an alternative Pneumocystis prophylactic for patients intolerant of trimethoprim-sulfamethoxazole.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Every living cell needs a special ingredient to build new DNA, like flour for baking bread. People get this ingredient ready-made from food, so they always have some on hand. Bacteria have to bake their own flour from scratch, using a tiny factory with two machines working one after another.
Sulfamethoxazole jams the first machine by pretending to be an ingredient it needs. Trimethoprim jams the second machine, further down the line. Jam only one machine and the factory slows way down but might limp along. Jam both at once and the factory shuts down completely, so the bacteria can't make new DNA and they die. Since people don't have this two-machine factory — we just eat our flour — the medicine barely bothers us while it wrecks the germs.
This combo treats bladder infections and a serious lung infection some very sick people get. But it can also cause a bad rash, nudge potassium up, and needs extra water to avoid forming little crystals, so doctors watch for those things.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient taking trimethoprim-sulfamethoxazole for a skin infection is also on an ACE inhibitor for hypertension. What combined risk should be monitored, and why?
Show answer
Combined hyperkalemia risk
Both the ACE inhibitor and trimethoprim push potassium upward through different mechanisms, so combining them raises the risk of dangerously high potassium, meaning potassium levels need closer monitoring.
A young infant develops a urinary infection, and a clinician considers trimethoprim-sulfamethoxazole. Why might this drug be avoided in this age group?
Show answer
Kernicterus risk in newborns
Sulfonamides can displace bilirubin from its binding protein in the blood, letting more free bilirubin reach a young infant's brain and raising kernicterus risk, so the drug is generally avoided near term and in young infants.
Quick check
3 questions here. Answers stay hidden until you check.
Why is the combination bactericidal when each drug alone is only bacteriostatic?
Choose an answer, then check it.
Which electrolyte and renal finding is classically associated with trimethoprim's amiloride-like action on the distal tubule?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.